Academic Journal

MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative.

التفاصيل البيبلوغرافية
العنوان: MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative.
المؤلفون: Thunnissen, E., Lissenberg-Witte, B., Van Den Heuvel, M., Monkhorst, K., Skov, B., Sorensen, J., Mellemgaard, A., Dingemans, A., Speel, E., De Langen, J., Hashemi, S., Bahce, I., Van Der Drift, M., Büttner, R., Looijen Salomon, M., Gosney, J., Postmus, P.E., Samii, S., Duplaquet, F., Weynand, B.
المصدر: Journal of Thoracic Oncology; Oct2018 Supplement, Vol. 13, pS452-S452, 1p
قاعدة البيانات: Complementary Index
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2018.08.542